IRCT20111224008507N4招募中3 期
Double-blind placebo-controlled clinical trial of evaluating the effectiveness of Ivermectin in treatment of outpatients with COVID-19 in 2021
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with positive coronavirus rapid test or RT-PCR positive
- •No need for hospitalization
- •Weight >15 kg
- •Age >5 years
- •No treatment with antiviral drugs before and during the study
- •Informed consent for inclusion
排除标准
- •Underlying liver and kidney disease
- •Patients with acquired immunodeficiency
- •Pregnancy and lactation
研究者
相似试验
招募中
3 期
Evaluation of the effect of Ivermectin in treatment of patients admitted with COVID-19COVID-19 infection.COVID-19, virus identifiedU07.1IRCT20111224008507N5Mazandaran University of Medical Sciences1,000
招募中
2 期
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitisJPRN-jRCT2031200236Kawai Toshinao8
招募中
不适用
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitisChronic granulomatous disease associated colitisJPRN-UMIN000029324ational Center for Child Heath and Development8
已完成
2 期
Frankincense effect on urinary disorders in multiple sclerosisMultiple sclerosis.Demyelinating diseases of the central nervous systemIRCT2015071023144N1Ahvaz Jundishapur University of Medical Sciences68
已完成
2 期
Effect of frankincense in treatment of eczemaAtopic dermatitisIRCT20111105008013N5Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center66